LYTENAVA Trademark

Trademark Overview

On Tuesday, April 14, 2020, a trademark application was filed for LYTENAVA with the United States Patent and Trademark Office. The USPTO has given the LYTENAVA trademark a serial number of 88872045. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 22, 2024. This trademark is owned by Outlook Therapeutics, Inc.. The LYTENAVA trademark is filed in the Pharmaceutical Products category with the following description:

injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
lytenava

General Information

Serial Number88872045
Word MarkLYTENAVA
Filing DateTuesday, April 14, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and Servicesinjectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 23, 2020
Primary Code005
First Use Anywhere DateMonday, August 29, 2022
First Use In Commerce DateMonday, August 29, 2022

Trademark Owner History

Party NameOutlook Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
Party NameOutlook Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Friday, April 17, 2020NEW APPLICATION ENTERED
Thursday, April 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 30, 2020ASSIGNED TO EXAMINER
Tuesday, June 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Thursday, March 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 25, 2021SOU EXTENSION 1 FILED
Thursday, March 25, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 2 GRANTED
Saturday, March 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021SOU EXTENSION 2 FILED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 25, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 25, 2022SOU EXTENSION 3 FILED
Friday, March 25, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 4 FILED
Thursday, September 22, 2022SOU EXTENSION 4 GRANTED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2023SOU EXTENSION 5 FILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 22, 2023SOU EXTENSION 5 GRANTED
Thursday, September 14, 2023TEAS STATEMENT OF USE RECEIVED
Monday, September 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023USE AMENDMENT FILED
Wednesday, November 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 8, 2023NON-FINAL ACTION E-MAILED
Monday, February 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, February 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 22, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 22, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

lytenava disease treatment retinal ophthalmic drugs namely pharmaceuticals injectable pharmaceutical preparations